Sirolimus-eluting Iron Bioresorbable Coronary Scaffold System

DEVICE2 trials

Sponsors

Lifetech Scientific (Shenzhen) Co., Ltd., Biotyx Medical (Shenzhen) Co., Ltd.

Conditions

Coronary Artery DiseaseSingle Coronary Vessel Disease

Unknown Phase

A First-in-Man Study of IBS

CompletedNCT03509142

Lifetech Scientific (Shenzhen) Co., Ltd.Single Coronary Vessel Disease

Start: 2018-04-10End: 2023-12-10Updated: 2025-04-25

A Clinical Trial to Evaluate the Safety and Efficacy of IBS in Patients With Coronary Artery Disease

Active, not recruitingNCT05205499

Biotyx Medical (Shenzhen) Co., Ltd.Coronary Artery Disease

Start: 2022-03-10End: 2028-08-31Updated: 2025-12-10